Traderboersenboard - Einzelnen Beitrag anzeigen - Wallstreet: Nachbörsliche Quartalsberichte , News und Kurse

Starlight · 24-02-2003, 21:18

Der DOW JONES verliert heute 159,87 Zähler oder 1,99% auf 7858,24 Punkte

Die Hightechs des Nasdaq Composite verlieren 26,65 Zähler oder 1,98% auf 1322,37 Punkte.

Meistgehandelte Aktie

Der NASDAQ 100 verliert 21,66 Zähler oder 2,09% auf 984,66Punkte

schwächer zeigte sich der Amex Interactiv Internet Index (IIX) , er verliert aktuell 1,48 Zähler bzw 1,76 Prozent auf 82,78 Punkte .

Der PHLX Semiconductor Sector (SOX) verliert 0,94 Zähler oder 0,32% auf 292,13Punkte

Der Amex Biotech Index (BTK) verliert 10,11 Zähler bzw. 3,09% auf 316,71Punkte

Der S&P 500 (SPX) verliert 15,59 Zähler oder 1,84% auf 832,58Punkte

*** EU/$ >> 1,079 ***

UP- and DOWNGRADES

AFTER THE CLOSE

Weight Watchers tops estimates; updates guidance (WTW) 39.34 -2.73: Reports Q4 (Dec) earnings of $0.26 per share, $0.01 better than the Multex consensus of $0.25; revenues rose 30.7% year/year to $190.1 mln vs the $178.6 mln consensus; says it is "comfortable with the analysts' current range of earnings estimates of $1.59 to $1.67 per share for the full year" -- Multex consensus estimate is for earnings of $1.43 per share.

Odyssey Healthcare tops estimates (ODSY) 22.94 +0.53: Reports Q4 (Dec) earnings of $0.28 per share, $0.05 better than the Multex consensus of $0.23; revenues rose 49% year/year to $57.0 mln vs the $54.8 mln consensus.

Corixa granted orphan status by the EC for lymphoma treatment (CRXA) 5.40 -0.23: The Orphan Medicinal Products designation has been granted on the basis that: follicular lymphoma affects fewer than 5 in 10,000 persons in the European Community.

Register.com misses by a penny (RCOM) 5.41 -0.09: Reports Q4 (Dec) loss of $0.01 per share, $0.01 worse than the Multex consensus of $0.00; revenues rose 3.9% year/year to $26.5 mln vs the $25.2 mln consensus.

Dycom matches estimates; guides Q3 lower (DY) 11.33 -0.22: Reports Q2 (Jan) loss of $0.02 per share, in line with the Multex consensus of ($0.02); revenues fell 0.8% year/year to $137.2 mln vs the $137.0 mln consensus; currently expects revenue for Q3 to range from $120.0 mln to $135.0 mln and diluted EPS to range from $0.02 to $0.06 -- Multex consensus estimates are $0.13 per share and $159.1 mln respectively.

Macrovision beats Q4 estimate; guides Q1, Y03 in-line (MVSN) 11.77 -0.47: Reports Q4 (Dec) earnings of $0.19 per share, $0.01 better than the Multex consensus of $0.18; revenues rose 11.9% year/year to $30.2 mln vs the $26.4 mln consensus; sees Q1 pro forma EPS of $0.14-$0.15, and sees FY03 EPS of $0.73-$0.75 (Multex consensus $0.15 and $0.72).

----------------------------------

Nachbörsliche WINNER+LOSER:

Regulärer Handel +After Hours- Top 100

____________________________________________

Nasdaq 100 Future

Nasdaq 100 After Hours Indicator

_____________________________________________
_____________________________________________

KURSLISTE in €

DAX ------------------------------ NEMAX 50

DOW JONES 30 ------------ NASDAQ 100

US-STOCKS ------------------- MDAX

--------------------------------------------------------------

24-02-2003, 21:18	#134
Starlight TBB Family Registriert seit: May 2002 Beiträge: 33.345	Der DOW JONES verliert heute 159,87 Zähler oder 1,99% auf 7858,24 Punkte Die Hightechs des Nasdaq Composite verlieren 26,65 Zähler oder 1,98% auf 1322,37 Punkte. Meistgehandelte Aktie Der NASDAQ 100 verliert 21,66 Zähler oder 2,09% auf 984,66Punkte schwächer zeigte sich der Amex Interactiv Internet Index (IIX) , er verliert aktuell 1,48 Zähler bzw 1,76 Prozent auf 82,78 Punkte . Der PHLX Semiconductor Sector (SOX) verliert 0,94 Zähler oder 0,32% auf 292,13Punkte Der Amex Biotech Index (BTK) verliert 10,11 Zähler bzw. 3,09% auf 316,71Punkte Der S&P 500 (SPX) verliert 15,59 Zähler oder 1,84% auf 832,58Punkte * EU/$ >> 1,079 * UP- and DOWNGRADES AFTER THE CLOSE Weight Watchers tops estimates; updates guidance (WTW) 39.34 -2.73: Reports Q4 (Dec) earnings of $0.26 per share, $0.01 better than the Multex consensus of $0.25; revenues rose 30.7% year/year to $190.1 mln vs the $178.6 mln consensus; says it is "comfortable with the analysts' current range of earnings estimates of $1.59 to $1.67 per share for the full year" -- Multex consensus estimate is for earnings of $1.43 per share. Odyssey Healthcare tops estimates (ODSY) 22.94 +0.53: Reports Q4 (Dec) earnings of $0.28 per share, $0.05 better than the Multex consensus of $0.23; revenues rose 49% year/year to $57.0 mln vs the $54.8 mln consensus. Corixa granted orphan status by the EC for lymphoma treatment (CRXA) 5.40 -0.23: The Orphan Medicinal Products designation has been granted on the basis that: follicular lymphoma affects fewer than 5 in 10,000 persons in the European Community. Register.com misses by a penny (RCOM) 5.41 -0.09: Reports Q4 (Dec) loss of $0.01 per share, $0.01 worse than the Multex consensus of $0.00; revenues rose 3.9% year/year to $26.5 mln vs the $25.2 mln consensus. Dycom matches estimates; guides Q3 lower (DY) 11.33 -0.22: Reports Q2 (Jan) loss of $0.02 per share, in line with the Multex consensus of ($0.02); revenues fell 0.8% year/year to $137.2 mln vs the $137.0 mln consensus; currently expects revenue for Q3 to range from $120.0 mln to $135.0 mln and diluted EPS to range from $0.02 to $0.06 -- Multex consensus estimates are $0.13 per share and $159.1 mln respectively. Macrovision beats Q4 estimate; guides Q1, Y03 in-line (MVSN) 11.77 -0.47: Reports Q4 (Dec) earnings of $0.19 per share, $0.01 better than the Multex consensus of $0.18; revenues rose 11.9% year/year to $30.2 mln vs the $26.4 mln consensus; sees Q1 pro forma EPS of $0.14-$0.15, and sees FY03 EPS of $0.73-$0.75 (Multex consensus $0.15 and $0.72). ---------------------------------- Nachbörsliche WINNER+LOSER: Regulärer Handel +After Hours- Top 100 ____________________________________________ Nasdaq 100 Future Nasdaq 100 After Hours Indicator _____________________________________________ _____________________________________________ KURSLISTE in € DAX ------------------------------ NEMAX 50 DOW JONES 30 ------------ NASDAQ 100 US-STOCKS ------------------- MDAX -------------------------------------------------------------- Geändert von Starlight (24-02-2003 um 21:52 Uhr)